MariMed Inc. (OTCMKTS:MRMD) Short Interest Up 151.5% in July

MariMed Inc. (OTCMKTS:MRMD) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 9,792 shares, a growth of 151.5% from the July 15th total of 3,893 shares. Based on an average daily trading volume, of 433,915 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

MariMed Stock Performance

OTCMKTS MRMD opened at $0.07 on Friday. The company’s 50 day moving average is $0.07 and its 200-day moving average is $0.08. MariMed has a 12-month low of $0.06 and a 12-month high of $0.23. The company has a quick ratio of 0.34, a current ratio of 0.95 and a debt-to-equity ratio of 1.67. The firm has a market cap of $26.08 million, a P/E ratio of -1.62 and a beta of 1.33.

MariMed (OTCMKTS:MRMD) last issued its quarterly earnings data on Wednesday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). MariMed had a negative return on equity of 10.33% and a negative net margin of 9.13%.The business had revenue of $41.92 million for the quarter, compared to analysts’ expectations of $39.80 million.

About MariMed

MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.